MK 0777Alternative Names: L-830982; MK-0777; TPA-023
Latest Information Update: 21 Oct 2009
At a glance
- Originator Merck Sharp & Dohme
- Class Antiepileptic drugs; Anxiolytics; Neuropsychotherapeutics
- Mechanism of Action GABA A alpha 2 receptor agonists; GABA A alpha 3 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Anxiety disorders; Schizophrenia